Phathom Pharmaceuticals (PHAT) Other Working Capital Changes (2018 - 2026)

Phathom Pharmaceuticals (PHAT) has 9 years of Other Working Capital Changes data on file, last reported at -$6.9 million in Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 11.42% year-over-year to -$6.9 million in Q1 2026; TTM through Mar 2026 was -$4.6 million, a 1595.47% decrease from a year earlier, with the FY2025 full-year figure at -$5.5 million, down 171.86% from the prior year.
• Other Working Capital Changes for Q1 2026 stood at -$6.9 million, down from $2.1 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for PHAT reached as high as $5.9 million in Q4 2024 and fell as low as -$7.8 million in Q1 2025.
• Historically, Other Working Capital Changes has averaged $304000.0 across 5 years, with a median of $254000.0 in 2023.
• Across the five-year window, Other Working Capital Changes surged 2218.11% in 2024 and slumped 1647.2% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at $4.2 million in 2022, then plunged by 93.88% to $254000.0 in 2023, then jumped by 2218.11% to $5.9 million in 2024, then plunged by 63.91% to $2.1 million in 2025, then plunged by 425.55% to -$6.9 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were -$6.9 million in Q1 2026, $2.1 million in Q4 2025, and -$1.4 million in Q3 2025.